Covered recipient · General Payments record
GEORGE B CLAVENNA
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$8,204.14
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $602.10 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $373.15 | 5 |
| Tarsus Pharmaceuticals, Inc. | $68.68 | 1 |
| Alcon Laboratories Inc | $45.52 | 3 |
| Dompe US, Inc. | $36.66 | 2 |
| Bausch & Lomb Americas Inc. | $33.47 | 2 |
| Oyster Point Pharma, Inc. | $28.35 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $16.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $129.74 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103478485 | CMS |
| ABBVIE INC. | $10.33 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103478487 | CMS |
| ABBVIE INC. | $95.14 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103478489 | CMS |
| ABBVIE INC. | $12.96 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103478491 | CMS |
| ABBVIE INC. | $124.98 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103478493 | CMS |
| Alcon Vision LLC | $16.29 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110558397 | CMS |
| Alcon Vision LLC | $14.00 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110558393 | CMS |
| Alcon Vision LLC | $15.23 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110558395 | CMS |
| Bausch & Lomb Americas Inc. | $16.27 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140347430 | CMS |
| Bausch & Lomb Americas Inc. | $17.20 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140347428 | CMS |
| Dompe US, Inc. | $22.69 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151403448 | CMS |
| Dompe US, Inc. | $13.97 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151403446 | CMS |
| Oyster Point Pharma, Inc. | $28.35 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147428091 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $16.27 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152150615 | CMS |
| Tarsus Pharmaceuticals, Inc. | $68.68 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139089296 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.